Nina Shah, MD, a professor of clinical medicine at the University of California, San Francisco, discusses management of multiple myeloma and her experience improving patients’ quality of life. Dr Shah also discusses the treatment decision-making process and the importance of communication between patients and providers. Finally, she discusses newer treatment options, including proteasome inhibitors, CAR T-cell therapy, and the benefit of clinical trials.